The FDA delivered a blow on Wednesday to the millions of cancer patients who face the prospect of declines in white blood cell counts during chemotherapy — a condition known as chemotherapy-induced neutropenia (CIN) — when it denied approval for a promising new agent that has been under Priority Review: Plinabulin. But the news is not all bad. The agency has asked the manufacturer to provide additional data to support its application, indicating that plinabulin might still play a part in future cancer care.Neutropenia increases the risk for infections; hospitalizations for major complications, including dangerously low blood pressure, renal and respiratory challenges, and heart failure; as well as in-hospital death. Data published in May 2018 in the Journal of Clinical Oncology suggested that over 100,000 cancer patients receiving chemotherapy are…
The pandemic led to a drop in U.S. road travel and a sharp increase in the number of people who chose to stay home all day.Liyao Xie/Getty Images Source link
Sildenafil is currently sold as Viagra to treat erectile dysfunction and as Revatio to improve the ability to exercise in adults with pulmonary arterial hypertension.John Greim/Getty Images Source link
A food handler working at a Starbucks had contracted the virus and had remained on the job through the infectious period.Joe Raedle/Getty Images Source link
According to the Centers for Disease Control and Prevention (CDC), nearly half of adults in the United States have high blood pressure.Getty Images Source link